Algert Global LLC Purchases 103,285 Shares of National Health Investors, Inc. $NHI

Algert Global LLC increased its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 70.9% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 248,865 shares of the real estate investment trust's stock after buying an additional 103,285 shares during the period. Algert Global LLC owned about 0.51% of National Health Investors worth $18,978,000 at the end of the most recent quarter.

A number of other institutional investors have also bought and sold shares of NHI. Renaissance Group LLC boosted its stake in shares of National Health Investors by 3.8% in the fourth quarter. Renaissance Group LLC now owns 3,206 shares of the real estate investment trust's stock worth $245,000 after acquiring an additional 117 shares during the period. Captrust Financial Advisors lifted its holdings in National Health Investors by 1.7% in the 4th quarter. Captrust Financial Advisors now owns 8,907 shares of the real estate investment trust's stock worth $680,000 after purchasing an additional 146 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in National Health Investors by 34.3% in the 1st quarter. EverSource Wealth Advisors LLC now owns 626 shares of the real estate investment trust's stock worth $51,000 after purchasing an additional 160 shares in the last quarter. Assetmark Inc. boosted its stake in National Health Investors by 13.5% in the 1st quarter. Assetmark Inc. now owns 1,356 shares of the real estate investment trust's stock worth $110,000 after purchasing an additional 161 shares during the period. Finally, Inspire Investing LLC boosted its stake in National Health Investors by 3.2% in the 1st quarter. Inspire Investing LLC now owns 6,310 shares of the real estate investment trust's stock worth $510,000 after purchasing an additional 198 shares during the period. Hedge funds and other institutional investors own 62.51% of the company's stock.

Insider Buying and Selling at National Health Investors

In other news, CEO D. Eric Mendelsohn acquired 1,500 shares of the company's stock in a transaction on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer directly owned 133,316 shares of the company's stock, valued at $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert A. Mccabe, Jr. acquired 890 shares of the business's stock in a transaction on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the transaction, the director directly owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. The trade was a 2.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 2.70% of the company's stock.

National Health Investors Stock Performance

National Health Investors stock opened at $73.02 on Tuesday. The company's 50-day moving average price is $75.53 and its 200-day moving average price is $79.03. National Health Investors, Inc. has a twelve month low of $67.94 and a twelve month high of $91.38. The company has a quick ratio of 6.78, a current ratio of 6.78 and a debt-to-equity ratio of 0.81. The company has a market cap of $3.59 billion, a PE ratio of 21.10, a price-to-earnings-growth ratio of 3.36 and a beta of 0.51.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The firm had revenue of $121.32 million during the quarter. During the same period in the previous year, the business posted $1.22 EPS. The firm's revenue was up 1.6% on a year-over-year basis. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities research analysts forecast that National Health Investors, Inc. will post 4.78 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, November 6th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 annualized dividend and a dividend yield of 5.0%. National Health Investors's payout ratio is currently 106.36%.

Analyst Upgrades and Downgrades

NHI has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating for the company in a research note on Thursday, June 25th. Zacks Research downgraded shares of National Health Investors from a "hold" rating to a "strong sell" rating in a report on Thursday, June 25th. Weiss Ratings lowered National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, June 12th. Wells Fargo & Company reduced their target price on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating on the stock in a report on Monday, June 1st. Finally, BMO Capital Markets decreased their target price on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a research report on Monday, June 15th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, National Health Investors presently has an average rating of "Moderate Buy" and an average target price of $83.86.

National Health Investors Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source